Cargando…
Prognostic value of RKIP and p-ERK in gastric cancer
BACKGROUND: The mitogen-activated protein kinase (MAPK) signaling pathway participates in several steps of tumour development and is considered a prominent therapeutic target for the design of chemotherapeutic agents. We evaluated the expressions of extracellular signal-regulated kinase (ERK), mitog...
Autores principales: | Fujimori, Yoshitaka, Inokuchi, Mikito, Takagi, Yoko, Kato, Keiji, Kojima, Kazuyuki, Sugihara, Kenichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351370/ https://www.ncbi.nlm.nih.gov/pubmed/22463874 http://dx.doi.org/10.1186/1756-9966-31-30 |
Ejemplares similares
-
EphA4 is a prognostic factor in gastric cancer
por: Miyazaki, Kohji, et al.
Publicado: (2013) -
Clinical significance of platelet derived growth factor-C and -D in gastric cancer
por: OGAWA, NORIHITO, et al.
Publicado: (2015) -
Therapeutic Targeting of Fibroblast Growth Factor Receptors in Gastric Cancer
por: Inokuchi, Mikito, et al.
Publicado: (2015) -
Impact of comorbidities on postoperative complications in patients undergoing laparoscopy-assisted gastrectomy for gastric cancer
por: Inokuchi, Mikito, et al.
Publicado: (2014) -
TPX2 expression is associated with poor survival in gastric cancer
por: Tomii, Chiharu, et al.
Publicado: (2017)